_id

690db078ccc777a4e85d0b83

Ticker

ARDS

Name

Aridis Pharmaceuticals Inc

Exchange

PINK

Address

983 University Avenue, Los Gatos, CA, United States, 95032

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.aridispharma.com

Description

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquired pneumonia and ventilator associated pneumonia. The company is also developing AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR 501, an inhaled gallium citrate, which is in Phase 1/2a for the treatment of chronic lung infection associated with cystic fibrosis; and AR-101, a human IgM mAb, which is in Phase II clinical trials targeting Pseudomonas aeruginosa liposaccharides serotype O11. In addition, it develops AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-701, a cocktail of two fully human immunoglobulin 1. The company was founded in 2003 and is headquartered in Los Gatos, California.

Last Close

0.0002

Volume

3796

Current Price

0.0002

Change

0

Last Updated

2025-11-28T12:21:22.282Z

Image

data:image/webp;base64,UklGRswIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSMkCAAABoK3tnyFJ+v0jqnrsmbVtWzcwOFrryMYV2LYPbdu2be/Yqoz///87KGVG3EBETABqDCNA2Gi34+754N/VTvrKP16/7vCdpwEYCcgxAJsfdd1fHPrTK+ZMg4TGAgL2v/17OlXNvZe7qpHp44s3g4g0IQHY8sHl9FQZh3XrKO3/a9dBiA20MfWytWRSZ62elFxw2ji06hJpzfmVZsYGzZ1v7oZYjwBXraWyaU/872RAaggY8whVmWEyXhckDBWw/rusnFma8oHxCEMINvqcyZmpV3x8DGQgwZi3qMxYeS8gA0jAo0zMWnkN4gARVzExb3c7Aa0+EYe6eWY0zt0TsYdgo99pzD7xhfGQLuAaJhaYeHqfbSoW6Zy7DgBEPEkvgs5rERFxyJJSjH9tgjCCe1ixUOUFaGOH32mlJL43FTiWFUt14yzg1oLY4eXYfAG9HOXH0/ekslw37nheUUw8/AlaScYrvqGX5HxqIYt2ft0pi1zghZmycPXSknlhmtYUxgVz6SU5v/6stKfvpZVkvPJ4aklrecQuZSl3XP8HWjmJH03H5azKWc0rgcOZvBQ3zgbW+4RaSuL7UzGCq5gK8Q4vQjtgi39ohfhfmyIg4iZ6Gat5AyIArLuYZfrc9dAtOJNVCat5NqTX5DeZ8kt8aUIvROw1n5ab+fy9ENG7hZPMPC9faaeghf4RNzLltZI3IGJAAR6iZuRr+QAgg0Aw9klWnouv5NNjIRg8YPxDVMtDV/GhcQgYNki4jpZySMYbowQML8DJ/zF5U97h3FMBQa0Ru71Od2vC1yrf2B0Bdbcw7rR5pCavx1MyzjtjHFqoPwasc81/Ru2oD+NpjVH/u2E9SECTIoLNzv+wQ7qqu3e5u1VGdj66YDOICJoOgqkzr/hY2W2uym77+KpZUyEBOYY2gKk7HX7lU18tUHq14Ounrjxip6kA2gE1AgBWUDgg3AUAABAXAJ0BKkAAQAA+rUKaSaYjoiEz+ZwAwBWJbACxJUFUHlpmN3/3QTYbfjymuZecP5gHOG8wHm5+gD0AP8B1IPoAeW/7K397/51s7bv/ynQLJH37ZRz1nzL+uGs++I9Cjnj+oOBz+0foqnmxW9lI+YNhpL+GmryMVVq9yNhsIlUdCQ588mZF4LhDyw8ba5VIlQohJbs+YgEC+CFRhksVdfYJoLA4UrXm7/hZln8Pq2tTDQfUJNbz/+wx/Gqi+oy2gAAA/v1ScQhVGi439hxSW2lLneqYEYUs1vwkO8bmiGpvuEuaNNImKnxE6O6334h22ERMHQdD/jKhFtw/nin3o1pE6oKRbHkjxNJ6LWCs+ECah9o1+5lBibx/1QV+5Lv5Z8804rNZGr/MTyyMHrwMX/+TYcwkJTbEm/ntgfYZFQC37tJy799184Otet+9VKG7zgtVH+KiwtsA8zWMeEtoeLeNjwHFl36PTgi5xWndd/eh2XxfcGLB+Rcd+sMXdIo0D7hf/ZhlGJUnOrIBGuOEfl1kkE8/bOvmKGzXZwOPuVLL8gALvNmP0dxJFahGBiqFW5KrxPiXHti8NxCBHXTAu4/zkEO5I4kITho+QKbVP/+612FO8/+Gb7aSdSBOPYlYSPRMHdItMQKqyK81LB5OdOd5COAXh1KBt7BoTyYQlnyBHPL86w6O0c7WGTppb93J3RuqNHqhrAXfQ/Hq4FLJm/Q+T5udT2Tc7kRyGJteTSV4lu8WOCEVRzA5y9S9XvyDZc98Rcrya6GtMXWQUTLwty41OTyEg8GWG3611ciCQNWrwiIrbA1NaTlw6U3sCNoShZbqt1BxoNFtT3ZOzxA7zuolP8rJ4pQD//dhUwR+h5yVzmRr7hnvd3t7PVcvMklPALRNpKJFBw21mBL9nMdf0my9EsFLRO8TF9OPpecbc1XgkzXqRQflsPLrS43kNwhr956K1fR5Q//0a0TGSZZCgULrT9HrzWi/44v7omx1jClcpHfPEytiyksI03Ogk+lhaDlFtg3ezNI80djFBf3HY38O7NsZ0ndCkdB3WX2JWRu96/nbkn03uZxRnniFQ8Ux7UGVzflR6zMkA0tXZS7v4DmxI774NGGcsiFPfjzxIhkt/ZKQsH4Gx0D5lUmkwQ341p9KTxJ6ppUwGncQsHe//g8IKBQ9HxV3V9WDm+wfSnhH1DjuxNSd8m3xHLPEf9+e/GEwJAaVb7u2wZcKgXdHx9jWu9cyL3dLX+L4S4rx2pkiiWd/dk8IV1NTrse3UP+tR3l7oTriOTV6MPc2zdt7f1u//v0+gPZqwS6sYWGhOU9+/zlLJbF0PnaUd6mJP8fHs9qMor754ozvkrZNXLwPuduyfuZnN6n2iMbOBmmo3YoAapdC1kI8/zVY+X3P+Vp+8cc7DD9XD6Mm1ydXfXqsKAK0pe6bpBzXVvtxj/TWf1nAIHpGgQiVG995FBLxy6mMednpxZ/iPHBwocncnNNVX4CJeQXbRzCG5j6a/PPInVpE2LrfAm4dnnZMAK8yLHywLYUheq2zsX4NRVR4ILq+PHS9yQUISblgJi79ujECR6hBTd4QcNqySWeY+a4LvwnWFMCCz3eUx9bZ2Dtw7Lui2TZtIEF7FVaWJj2M3RJoHsyu3aPC/gJxzOBo1WLNc4YQNfAZ5WQo7nZumJWQrXZB+6zJ4vBZSa9Yxlk41hLlVPoKicyesKqh4nQBQrb/LbWjOV2ZvTV3Tm01ioiR5YNUoJNXT9HlLXYhm7+xat3By5xT/Fy6gOj3fHoJnJModh1Sodieh1x6ByDXa9fwDXQpNOeNKOokS7F7BrAeHsAlTzxALNih0hiXZ6y9DzeBvE/N85EAOGHgRluc2J89ODFGF4AkPlDJdRavVuinmIavS0xtWBDb/m15D4sxXK4gMAPGCUA6yJPInppJTltFeByiNaK7Q/DNIdtORdAuN76jr0IVPTVk3hJm/Pow5EDAVL7BhmMeq+pf7QX4T0AAAA==

Ipo Date

2018-08-10T00:00:00.000Z

Market Cap

8915

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4

Target Price

2

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2023-09-30

Revenue

417000

Cost Of Revenue

-

Gross Profit

417000

Operating Expenses

869000

Operating Income

-869000

Interest Expense

1000

Pretax Income

-83000

Net Income

-83000

Eps

-0.0022175352373696475

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-60000

EBITDA

-810000

Operating Margin

-208.39328537170263

Total Other Income Expense Net

786000

Cash

35000

Short Term Investments

-

Receivables

517000

Inventories

-517000

Total Current Assets

4110000

Property Plant Equipment

1584000

Total Assets

6534000

Payables

5410000

Short Term Debt

3986000

Long Term Debt

-

Total Liabilities

18336000

Equity

-11802000

Depreciation

59000

Change In Working Capital

-1835000

Cash From Operations

-983000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

999000

Net Change In Cash

16000

PE

-

PB

-0.0006342813590916793

ROE

0.7032706320962548

ROA

-1.2702785430058157

FCF

-983000

Fcf Percent

-2.357314148681055

Piotroski FScore

0

Health Score

15

Deep Value Investing Score

2.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

1

Growth Investing Score

1.5

Momentum Investing Score

5

Net Net Investing Score

2

Quality Investing Score

1

Value Investing Score

1

Quarters > 0 > quarter

2023-09-30

Quarters > 0 > income Statement > revenue

417000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

417000

Quarters > 0 > income Statement > operating Expenses

869000

Quarters > 0 > income Statement > operating Income

-869000

Quarters > 0 > income Statement > interest Expense

1000

Quarters > 0 > income Statement > pretax Income

-83000

Quarters > 0 > income Statement > net Income

-83000

Quarters > 0 > income Statement > eps

-0.0022175352373696475

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

37428943

Quarters > 0 > income Statement > income Tax Expense

-60000

Quarters > 0 > income Statement > EBITDA

-810000

Quarters > 0 > income Statement > operating Margin

-208.39328537170263

Quarters > 0 > income Statement > total Other Income Expense Net

786000

Quarters > 0 > balance Sheet > cash

35000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

517000

Quarters > 0 > balance Sheet > inventories

-517000

Quarters > 0 > balance Sheet > total Current Assets

4110000

Quarters > 0 > balance Sheet > property Plant Equipment

1584000

Quarters > 0 > balance Sheet > total Assets

6534000

Quarters > 0 > balance Sheet > payables

5410000

Quarters > 0 > balance Sheet > short Term Debt

3986000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

18336000

Quarters > 0 > balance Sheet > equity

-11802000

Quarters > 0 > cash Flow > net Income

-83000

Quarters > 0 > cash Flow > depreciation

59000

Quarters > 0 > cash Flow > change In Working Capital

-1835000

Quarters > 0 > cash Flow > cash From Operations

-983000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

999000

Quarters > 0 > cash Flow > net Change In Cash

16000

Quarters > 0 > ratios > PE

-0.0022175352373696475

Quarters > 0 > ratios > PB

-0.0006342813590916793

Quarters > 0 > ratios > ROE

0.7032706320962548

Quarters > 0 > ratios > ROA

-1.2702785430058157

Quarters > 0 > ratios > FCF

-983000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-2.357314148681055

Quarters > 0 > health Score

15

Quarters > 1 > quarter

2023-06-30

Quarters > 1 > income Statement > revenue

19647000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

19647000

Quarters > 1 > income Statement > operating Expenses

5978000

Quarters > 1 > income Statement > operating Income

13669000

Quarters > 1 > income Statement > interest Expense

3000

Quarters > 1 > income Statement > pretax Income

12144000

Quarters > 1 > income Statement > net Income

12144000

Quarters > 1 > income Statement > eps

0.3320485954650649

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

36572960

Quarters > 1 > income Statement > income Tax Expense

-3000

Quarters > 1 > income Statement > EBITDA

13732000

Quarters > 1 > income Statement > operating Margin

69.57296279330177

Quarters > 1 > income Statement > total Other Income Expense Net

-1525000

Quarters > 1 > balance Sheet > cash

19000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

300000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

3884000

Quarters > 1 > balance Sheet > property Plant Equipment

1757000

Quarters > 1 > balance Sheet > total Assets

6482000

Quarters > 1 > balance Sheet > payables

6237000

Quarters > 1 > balance Sheet > short Term Debt

5293000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

21396000

Quarters > 1 > balance Sheet > equity

-14914000

Quarters > 1 > cash Flow > net Income

12144000

Quarters > 1 > cash Flow > depreciation

63000

Quarters > 1 > cash Flow > change In Working Capital

-16829000

Quarters > 1 > cash Flow > cash From Operations

-4343000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

14000

Quarters > 1 > cash Flow > cash From Financing

3028000

Quarters > 1 > cash Flow > net Change In Cash

-1301000

Quarters > 1 > ratios > PE

0.3320485954650649

Quarters > 1 > ratios > PB

-0.0004904513879576237

Quarters > 1 > ratios > ROE

-81.4268472576103

Quarters > 1 > ratios > ROA

187.34958346189447

Quarters > 1 > ratios > FCF

-4343000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.22105156003461088

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2023-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

6263000

Quarters > 2 > income Statement > operating Income

-6263000

Quarters > 2 > income Statement > interest Expense

27000

Quarters > 2 > income Statement > pretax Income

-6816000

Quarters > 2 > income Statement > net Income

-6816000

Quarters > 2 > income Statement > eps

-0.22410094537654532

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

30414865

Quarters > 2 > income Statement > income Tax Expense

526000

Quarters > 2 > income Statement > EBITDA

-6176000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-553000

Quarters > 2 > balance Sheet > cash

1320000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

100000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

6566000

Quarters > 2 > balance Sheet > property Plant Equipment

1947000

Quarters > 2 > balance Sheet > total Assets

9434000

Quarters > 2 > balance Sheet > payables

4119000

Quarters > 2 > balance Sheet > short Term Debt

2798000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

37316000

Quarters > 2 > balance Sheet > equity

-27882000

Quarters > 2 > cash Flow > net Income

-6816000

Quarters > 2 > cash Flow > depreciation

87000

Quarters > 2 > cash Flow > change In Working Capital

1877000

Quarters > 2 > cash Flow > cash From Operations

-4002000

Quarters > 2 > cash Flow > capital Expenditures

49000

Quarters > 2 > cash Flow > cash From Investing

-49000

Quarters > 2 > cash Flow > cash From Financing

263000

Quarters > 2 > cash Flow > net Change In Cash

-3739000

Quarters > 2 > ratios > PE

-0.22410094537654532

Quarters > 2 > ratios > PB

-0.00021816845993831145

Quarters > 2 > ratios > ROE

24.445879061760277

Quarters > 2 > ratios > ROA

-72.24931100275599

Quarters > 2 > ratios > FCF

-4051000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2022-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

7420000

Quarters > 3 > income Statement > operating Income

-7420000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-6387000

Quarters > 3 > income Statement > net Income

-6387000

Quarters > 3 > income Statement > eps

-0.23626213548418312

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

27033532

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7320000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

887000

Quarters > 3 > balance Sheet > cash

4876000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

1000000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

11626000

Quarters > 3 > balance Sheet > property Plant Equipment

2147000

Quarters > 3 > balance Sheet > total Assets

14695000

Quarters > 3 > balance Sheet > payables

2308000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

38927000

Quarters > 3 > balance Sheet > equity

-24232000

Quarters > 3 > cash Flow > net Income

-10495000

Quarters > 3 > cash Flow > depreciation

63000

Quarters > 3 > cash Flow > change In Working Capital

-1667000

Quarters > 3 > cash Flow > cash From Operations

-4343000

Quarters > 3 > cash Flow > capital Expenditures

49000

Quarters > 3 > cash Flow > cash From Investing

14000

Quarters > 3 > cash Flow > cash From Financing

3028000

Quarters > 3 > cash Flow > net Change In Cash

-1301000

Quarters > 3 > ratios > PE

-0.23626213548418312

Quarters > 3 > ratios > PB

-0.00022312258171013538

Quarters > 3 > ratios > ROE

26.35770881479036

Quarters > 3 > ratios > ROA

-43.46376318475672

Quarters > 3 > ratios > FCF

-4392000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

39

Valuation > metrics > PE

-0.0022175352373696475

Valuation > metrics > PB

-0.0006342813590916793

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

0.7032706320962548

Profitability > metrics > ROA

-2.019464720194647

Profitability > metrics > Net Margin

-0.19904076738609114

Profitability > final Score

1

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-869

Risk > final Score

-3446

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.43742017879948913

Liquidity > metrics > Quick Ratio

0.49244359301830565

Liquidity > final Score

35

Liquidity > verdict

Weak

Prev Valuations > 0

70

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

60

Prev Profitabilities > 1

55

Prev Profitabilities > 2

55

Prev Risks > 0

70

Prev Risks > 1

-898

Prev Risks > 2

-2

Prev Liquidities > 0

27

Prev Liquidities > 1

57

Prev Liquidities > 2

100

Updated At

2025-12-16T22:25:10.411Z